TipRanks
Advertisement
Advertisement

MX:ARWR Stock Latest News

Arrowhead announces interim topline data from Phase 1/2a trial of ARO-DIMER-PA
The FlyArrowhead announces interim topline data from Phase 1/2a trial of ARO-DIMER-PA
8h ago
ARWR
Citi adds ‘upside 30-day catalyst watch’ on Arrowhead
PremiumThe Fly
Citi adds ‘upside 30-day catalyst watch’ on Arrowhead
6d ago
ARWR
Arrowhead initiated with a Buy at Citi
PremiumThe Fly
Arrowhead initiated with a Buy at Citi
7d ago
ARWR
Arrowhead Phase 3 SHASTA-3, SHASTA-4 studies met primary endpoints
PremiumThe Fly
Arrowhead Phase 3 SHASTA-3, SHASTA-4 studies met primary endpoints
16d ago
ARWR
Arrowhead announces availability of REDEMPLO for FCS in Germany
PremiumThe Fly
Arrowhead announces availability of REDEMPLO for FCS in Germany
29d ago
ARWR
Arrowhead Pharmaceuticals Earnings Call Signals Confident Expansion
PremiumCompany AnnouncementsArrowhead Pharmaceuticals Earnings Call Signals Confident Expansion
1M ago
ARWR
Arrowhead price target raised to $120 from $115 at H.C. Wainwright
Premium
The Fly
Arrowhead price target raised to $120 from $115 at H.C. Wainwright
1M ago
ARWR
Arrowhead: Buy Rating Reiterated as Redemplo Momentum Builds and Pipeline Catalysts Support Unchanged $120 Price Target
Premium
Ratings
Arrowhead: Buy Rating Reiterated as Redemplo Momentum Builds and Pipeline Catalysts Support Unchanged $120 Price Target
1M ago
ARWR
Arrowhead price target raised to $104 from $98 at Stifel
PremiumThe Fly
Arrowhead price target raised to $104 from $98 at Stifel
1M ago
ARWR
Arrowhead: Strong Phase III Plozasiran Data and Priority Review Voucher Drive Accelerated Path to Market and $3B Global Sales Outlook, Supporting Buy Rating
PremiumRatings
Arrowhead: Strong Phase III Plozasiran Data and Priority Review Voucher Drive Accelerated Path to Market and $3B Global Sales Outlook, Supporting Buy Rating
1M ago
ARWR
Arrowhead reports Q3 EPS ($1.36), consensus ($1.23)
PremiumThe Fly
Arrowhead reports Q3 EPS ($1.36), consensus ($1.23)
1M ago
ARWR
Arrowhead acquires FDA priority review voucher
PremiumThe Fly
Arrowhead acquires FDA priority review voucher
1M ago
ARWR
Is ARWR a Buy, Before Earnings?
PremiumPre-EarningsIs ARWR a Buy, Before Earnings?
1M ago
ARWR
Arrowhead price target raised to $123 from $101 at B. Riley
Premium
The Fly
Arrowhead price target raised to $123 from $101 at B. Riley
2M ago
ARWR
Arrowhead completes enrollment in Phase 3 YOSEMITE trial
Premium
The Fly
Arrowhead completes enrollment in Phase 3 YOSEMITE trial
2M ago
ARWR
Arrowhead price target raised to $115 from $100 at H.C. Wainwright
PremiumThe Fly
Arrowhead price target raised to $115 from $100 at H.C. Wainwright
2M ago
ARWR
Arrowhead price target raised to $120 from $100 at Morgan Stanley
PremiumThe Fly
Arrowhead price target raised to $120 from $100 at Morgan Stanley
2M ago
ARWR
Arrowhead price target raised to $126 from $110 at Piper Sandler
PremiumThe Fly
Arrowhead price target raised to $126 from $110 at Piper Sandler
2M ago
ARWR
Arrowhead price target raised to $115 from $90 at Chardan
PremiumThe Fly
Arrowhead price target raised to $115 from $90 at Chardan
2M ago
ARWR
Midday Fly By: AT&T reports Q2 beat, AMD invests $5B in Anthropic
PremiumThe FlyMidday Fly By: AT&T reports Q2 beat, AMD invests $5B in Anthropic
2M ago
T
PM
Arrowhead rises 23.4%
Premium
The Fly
Arrowhead rises 23.4%
2M ago
ARWR
Arrowhead rises 22.7%
Premium
The Fly
Arrowhead rises 22.7%
2M ago
ARWR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >